Released Aug 7, 2017, after the close
10-Q filed Aug 7, 2017, 38 days after period end · 0001564590-17-015993
Q2 2017 · 10-Q
Revenue$108.94M$108.94M +4.7% vs Q2 2016+6.0% vs Q1 2017
Net Income$3.85M$3.85M N/M vs Q2 2016N/M vs Q1 2017
EPS Diluted$0.21$0.21 N/M vs Q2 2016N/M vs Q1 2017
Gross Profit$85,765,000+5.2%
Operating Income$7,998,000N/M
Operating Cash Flowderived$6,257,000−62.6%
Free Cash Flowderived$2,943,000−77.7%
Margins · derived
Gross margin78.7%+0.4 pt vs Q2 2016
Operating margin7.3%+9.9 pt vs Q2 2016
Net margin3.5%+10.7 pt vs Q2 2016
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q2 2017 | Q2 2016 | Q2 2015 | Q2 2014 |
|---|---|---|---|---|
| Revenue | $108.94M | $104.08M | $100.95M | $100.99M |
| Net Income | $3.85M | -$7.44M | $3.57M | -$683.00K |
| EPS Diluted | $0.21 | -$0.41 | $0.19 | -$0.04 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Orthofix Medical Inc. · CIK 884624 · Engraved from SEC EDGAR